Two Medical Giants Diverge in Strategy as Investors Face a Choice Between Steady Returns and High Growth Nov 13, 2026 Life Science
Health Care Emerges as Defensive Haven as AI Trade Stumbles, Investors Rotate In Nov 13, 2026 Life Science, Technology
What Eli Lilly’s China Approval for Oral GLP-1 Weight-Loss Drug Means for Investors Nov 12, 2026 Life Science
Novo Nordisk Weight-Loss Drug Prescriptions Top Eight Million, JPMorgan Casts a Vote of Confidence Nov 11, 2026 Life Science
Roche Advances Trademark Filings as New Breast Cancer Drug Awaits Regulatory Review Nov 11, 2026 Life Science
Pfizer Delivers Strong Quarterly Results and Partners with Blackstone to Advance Weight-Loss Drug Development Nov 11, 2026 Life Science
Viking Therapeutics Emerges as Potential Dark Horse in Weight-Loss Drug Race Amid Eli Lilly’s Dominance Nov 11, 2026 Life Science
Weight-Loss Drug Market Remains Hot, Dietary Supplements Usher in Supporting Development Opportunities Nov 10, 2026 Life Science
Novo Nordisk’s 2026 Transition Year: Early Wegovy Pill Success Meets Weak Earnings and a Stock Down 20% Over Five Years Nov 8, 2026 Life Science
Hims & Hers and Intuitive Surgical Diverge on Growth Paths, Investors Must Weigh Risk Against Valuation Nov 7, 2026 Life Science
Moderna Returns to Profit After Two Years, Sparking Valuation Debate on 720% 2026 Surge Nov 6, 2026 Life Science
Vertex Pharmaceuticals’ Core Business Grows Steadily, Diversified Layout Begins to Show Results Nov 6, 2026 Life Science
Hospital Stocks Rally on Democratic Congress Takeover, But Is the Optimism Overdone? Nov 5, 2026 Financial Service, Life Science
S&P 500 Keeps Falling, and Three High-Dividend Stocks Present Good Buying Opportunities Nov 3, 2026 Life Science, Real Estate, Technology
Moderna Soars Over 600% This Year, Personalized Cancer Vaccine Becomes Key Catalyst Nov 3, 2026 Life Science
CVS Health Reportedly Plans to Split into Two Independent Entities as Business Restructuring Rumors Materialize Nov 3, 2026 Life Science
